Orexo Wins U.S. Backing for Opioid-Addiction Tablet

Orexo AB won U.S. regulatory approval for a tablet to treat addiction to heroin and prescription painkillers. The Swedish drugmaker’s stock surged to the highest price in more than five years.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.